Morbidity and mortality in patients on dialysis: the impact of hemoglobin levels.
Clinical reports supporting an association between hemoglobin (Hb) levels, morbidity, and mortality were a strong part of the dataset used by the National Kidney Foundation in recommending a target Hb level of 11 to 12 g/dL in patients on dialysis. This article provides an overview of the potential link between Hb correction and improvements in morbidity and mortality in patients on dialysis.